|Articles|December 6, 2021
Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial
Author(s)WCG
Site augmentation helps expedite COVID-19 vaccine trial by enrolling over 30,000 study participants in just over three months.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
2
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
3
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
4
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
5